Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Anthera Pharma Prices $40 Mln Stock Offering

Anthera Pharmaceuticals, Inc. (ANTH: Quote) said Friday that it has priced an underwritten public offering of about 60.6 million shares of its common stock, offered at a price of $0.66 per share.

The company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $40.0 million.

In addition, the company has granted the underwriters a 30-day option to purchase up to an additional about 9.1 million shares of common stock.

The offering is expected to close on or about January 30.

The company plans to use the net proceeds from the offering for general corporate purposes.

Click here to receive FREE breaking news email alerts for Anthera Pharmaceuticals, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The private sector in the eurozone logged a marginal upturn in October helped by an improvement in Germany, while France moved deeper into contraction, flash data from Markit Economics revealed Thursday. The headline flash Markit composite output index rose to 52.2 in October from a 10-month low of 52 in September. The score was forecast to fall to 51.5. After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.